Accurate determination of human epidermal growth factor receptor 2 (HER2) expression is critical for guiding targeted therapy in breast cancer. This study aimed to develop and validate a deep learning (DL)-based decision-making visual biomarker system (DM-VBS) for predicting HER2 status using radiomics and DL features derived from magnetic resonance imaging (MRI) and mammography (MG). Radiomics features were extracted from MRI, and DL features were derived from MG. Four submodels were constructed: Model I (MRI-radiomics) and Model III (mammography-DL) for distinguishing HER2-zero/low from HER2-positive cases, and Model II (MRI-radiomics) and Model IV (mammography-DL) for differentiating HER2-zero from HER2-low/positive cases. These submodels were integrated into a XGBoost model for ternary classification of HER2 status. Radiologists assessed imaging features associated with HER2 expression, and model performance was validated using two independent datasets from The Cancer Image Archive. A total of 550 patients were divided into training, internal validation, and external validation cohorts. Models I and III achieved an area under the curve (AUC) of 0.800-0.850 for distinguishing HER2-zero/low from HER2-positive cases, while Models II and IV demonstrated AUC values of 0.793-0.847 for differentiating HER2-zero from HER2-low/positive cases. The DM-VBS achieved average accuracy of 85.42%, 80.4%, and 89.68% for HER2-zero, -low, and -positive patients in the validation cohorts, respectively. Imaging features such as lesion size, number of lesions, enhancement type, and microcalcifications significantly differed across HER2 statuses, except between HER2-zero and -low groups. DM-VBS can predict HER2 status and assist clinicians in making treatment decisions for breast cancer.

This study aimed to compare CT features of COVID-19 and Influenza A pneumonia, develop a diagnostic differential model, and explore a prognostic model for lesion resolution. A total of 446 patients diagnosed with COVID-19 and 80 with Influenza A pneumonitis underwent baseline chest CT evaluation. Logistic regression analysis was conducted after multivariate analysis and the results were presented as nomograms. Machine learning models were also evaluated for their diagnostic performance. Prognostic factors for lesion resolution were analyzed using Cox regression after excluding patients who were lost to follow-up, with a nomogram being created. COVID-19 patients showed more features such as thickening of bronchovascular bundles, crazy paving sign and traction bronchiectasis. Influenza A patients exhibited more features such as consolidation, coarse banding and pleural effusion (P < 0.05). The logistic regression model achieved AUC values of 0.937 (training) and 0.931 (validation). Machine learning models exhibited area under the curve values ranging from 0.8486 to 0.9017. COVID-19 patients showed better lesion resolution. Independent prognostic factors for resolution at baseline included age, sex, lesion distribution, morphology, coarse banding, and widening of the main pulmonary artery. Distinct imaging features can differentiate COVID-19 from Influenza A pneumonia. The logistic discriminative model and each machine - learning network model constructed in this study demonstrated efficacy. The nomogram for the logistic discriminative model exhibited high utility. Patients with COVID-19 may exhibit a better resolution of lesions. Certain baseline characteristics may act as independent prognostic factors for complete resolution of lesions.

This study aimed to develop and validate a predictive model to detect osteoporosis using radiomic features and machine learning (ML) approaches from lumbar spine computed tomography (CT) images during an abdominal CT examination. A total of 509 patients who underwent both quantitative CT (QCT) and abdominal CT examinations (training group, n = 279; internal validation group, n = 120; external validation group, n = 110) were analyzed in this retrospective study from two centers. Radiomic features were extracted from the lumbar spine CT images. Seven radiomic-based ML models, including logistic regression (LR), Bernoulli, Gaussian NB, SGD, decision tree, support vector machine (SVM), and K-nearest neighbor (KNN) models, were constructed. The performance of the models was assessed using the area under the curve (AUC) of receiver operating characteristic (ROC) curve analysis and decision curve analysis (DCA). The radiomic model based on LR in the internal validation group and external validation group had excellent performance, with an AUC of 0.960 and 0.786 for differentiating osteoporosis from normal BMD and osteopenia, respectively. The radiomic model based on LR in the internal validation group and Gaussian NB model in the external validation group yielded the highest performance, with an AUC of 0.905 and 0.839 for discriminating normal BMD from osteopenia and osteoporosis, respectively. DCA in the internal validation group revealed that the LR model had greater net benefit than the other models in differentiating osteoporosis from normal BMD and osteopenia. Radiomic-based ML approaches may be used to predict osteoporosis from abdominal CT images and as a tool for opportunistic osteoporosis screening.

Artificial intelligence (AI) models have been applied to differential dementia detection tasks in brain images from curated, high-quality benchmark databases, but not real-world data in hospitals. We describe a deep learning model specially trained for disease detection in heterogeneous clinical images from electronic health records without focusing on confounding factors. It encodes up to 14 multimodal images, alongside age and demographics, and outputs the likelihood of vascular dementia, Alzheimer's, Lewy body dementia, Pick's disease, mild cognitive impairment, and unspecified dementia. We use data from Massachusetts General Hospital (183,018 images from 11,015 patients) for training and external data (125,493 images from 6,662 patients) for testing. Performance ranged between 0.82 and 0.94 area under the curve (AUC) on data from 1003 sites. Analysis shows that the model focused on subcortical brain structures as the basis for its decisions. By detecting biomarkers in real-world data, the presented techniques will help with clinical translation of disease detection AI. Our artificial intelligence (AI) model can detect neurodegenerative disorders in brain imaging electronic health record (EHR) data. It encodes up to 14 brain images and text information from a single patient's EHR. Attention maps show that the model focuses on subcortical brain structures. Performance ranged from 0.82 to 0.94 area under the curve (AUC) on data from 1003 external sites.

In the context of precision medicine, radiomics has become a key technology in solving medical problems. For adenocarcinoma of esophagogastric junction (AEG), developing a preoperative CT-based prediction model for AEG invasion and lymph node metastasis is crucial. We retrospectively collected 256 patients with AEG from two centres. The radiomics features were extracted from the preoperative diagnostic CT images, and the feature selection method and machine learning method were applied to reduce the feature size and establish the predictive imaging features. By comparing the three machine learning methods, the best radiomics nomogram was selected, and the average AUC was obtained by 20 repeats of fivefold cross-validation for comparison. The fusion model was constructed by logistic regression combined with clinical factors. On this basis, ROC curve, calibration curve and decision curve of the fusion model are constructed. The predictive efficacy of fusion model for tumour invasion depth was higher than that of radiomics nomogram, with an AUC of 0.764 vs. 0.706 in the test set, P < 0.001, internal validation set 0.752 vs. 0.697, P < 0.001, and external validation set 0.756 vs. 0.687, P < 0.001, respectively. The predictive efficacy of the lymph node metastasis fusion model was higher than that of the radiomics nomogram, with an AUC of 0.809 vs. 0.732 in the test set, P < 0.001, internal validation set 0.841 vs. 0.718, P < 0.001, and external validation set 0.801 vs. 0.680, P < 0.001, respectively. We have developed a fusion model combining radiomics and clinical risk factors, which is crucial for the accurate preoperative diagnosis and treatment of AEG, advancing precision medicine. It may also spark discussions on the imaging feature differences between AEG and GC (Gastric cancer).

T2-weighted imaging (T2WI), renowned for its sensitivity to edema and lesions, faces clinical limitations due to prolonged scanning time, increasing patient discomfort, and motion artifacts. The individual applications of artificial intelligence-assisted compressed sensing (ACS) and deep learning-based reconstruction (DLR) technologies have demonstrated effectiveness in accelerated scanning. However, the synergistic potential of ACS combined with DLR at 5.0T remains unexplored. This study systematically evaluates the diagnostic efficacy of the integrated ACS-DLR technique for T2WI at 5.0T, comparing it to conventional parallel imaging (PI) protocols. The prospective analysis was performed on 98 participants who underwent brain T2WI scans using ACS, DLR, and PI techniques. Two observers evaluated the overall image quality, truncation artifacts, motion artifacts, cerebrospinal fluid flow artifacts, vascular pulsation artifacts, and the significance of lesions. Subjective rating differences among the three sequences were compared. Objective assessment involved the signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) in gray matter, white matter, and cerebrospinal fluid for each sequence. The SNR, CNR, and acquisition time of each sequence were compared. The acquisition time for ACS and DLR was reduced by 78%. The overall image quality of DLR is higher than that of ACS (P < 0.001) and equivalent to PI (P > 0.05). The SNR of the DLR sequence is the highest, and the CNR of DLR is higher than that of the ACS sequence (P < 0.001) and equivalent to PI (P > 0.05). The integration of ACS and DLR enables the ultrafast acquisition of brain T2WI while maintaining superior SNR and comparable CNR compared to PI sequences. Not applicable.

This study aimed to identify the hyoid bone (HB) using the nnU-Net based artificial intelligence (AI) model in cone beam computed tomography (CBCT) images and assess the model's success in automatic segmentation. CBCT images of 190 patients were randomly selected. The raw data was converted to DICOM format and transferred to the 3D Slicer Imaging Software (Version 4.10.2; MIT, Cambridge, MA, USA). HB was labeled manually using the 3D Slicer. The dataset was divided into training, validation, and test sets in a ratio of 8:1:1. The nnU-Net v2 architecture was utilized to process the training and test datasets, generating the algorithm weight factors. To assess the model's accuracy and performance, a confusion matrix was employed. F1-score, Dice coefficient (DC), 95% Hausdorff distance (95% HD), and Intersection over Union (IoU) metrics were calculated to evaluate the results. The model's performance metrics were as follows: DC = 0.9434, IoU = 0.8941, F1-score = 0.9446, and 95% HD = 1.9998. The receiver operating characteristic (ROC) curve was generated, yielding an AUC value of 0.98. The results indicated that the nnU-Net v2 model achieved high precision and accuracy in HB segmentation on CBCT images. Automatic segmentation of HB can enhance clinicians' decision-making speed and accuracy in diagnosing and treating various clinical conditions. Not applicable.

Papillary thyroid microcarcinoma (PTMC) is the most common malignant subtype of thyroid cancer. Preoperative assessment of the risk of central compartment lymph node metastasis (CCLNM) can provide scientific support for personalized treatment decisions prior to microwave ablation of thyroid nodules. The objective of this study was to develop a predictive model for CCLNM in patients with solitary PTMC on the basis of a combination of ultrasound radiomics and clinical parameters. We retrospectively analyzed data from 480 patients diagnosed with PTMC via postoperative pathological examination. The patients were randomly divided into a training set (n = 336) and a validation set (n = 144) at a 7:3 ratio. The cohort was stratified into a metastasis group and a nonmetastasis group on the basis of postoperative pathological results. Ultrasound radiomic features were extracted from routine thyroid ultrasound images, and multiple feature selection methods were applied to construct radiomic models for each group. Independent risk factors, along with radiomics features identified through multivariate logistic regression analysis, were subsequently refined through additional feature selection techniques to develop combined predictive models. The performance of each model was then evaluated. The combined model, which incorporates age, the presence of Hashimoto's thyroiditis (HT), and radiomics features selected via an optimal feature selection approach (percentage-based), exhibited superior predictive efficacy, with AUC values of 0.767 (95% CI: 0.716-0.818) in the training set and 0.729 (95% CI: 0.648-0.810) in the validation set. A machine learning-based model combining ultrasound radiomics and clinical variables shows promise for the preoperative risk stratification of CCLNM in patients with PTMC. However, further validation in larger, more diverse cohorts is needed before clinical application. Not applicable.

The composition of the tumour microenvironment is very complex, and measuring the extent of immune cell infiltration can provide an important guide to clinically significant treatments for cancer, such as immune checkpoint inhibition therapy and targeted therapy. We used multiple machine learning (ML) models to predict differences in immune infiltration in clear cell renal cell carcinoma (ccRCC), with computed tomography (CT) imaging pictures serving as a model for machine learning. We also statistically analysed and compared the results of multiple typing models and explored an excellent non-invasive and convenient method for treatment of ccRCC patients and explored a better, non-invasive and convenient prediction method for ccRCC patients. The study included 539 ccRCC samples with clinicopathological information and associated genetic information from The Cancer Genome Atlas (TCGA) database. The Single Sample Gene Set Enrichment Analysis (ssGSEA) algorithm was used to obtain the immune cell infiltration results as well as the cluster analysis results. ssGSEA-based analysis was used to obtain the immune cell infiltration levels, and the Boruta algorithm was further used to downscale the obtained positive/negative gene sets to obtain the immune infiltration level groupings. Multifactor Cox regression analysis was used to calculate the immunotherapy response of subgroups according to Tumor Immune Dysfunction and Exclusion (TIDE) algorithm and subgraph algorithm to detect the difference in survival time and immunotherapy response of ccRCC patients with immune infiltration. Radiomics features were screened using LASSO analysis. Eight ML algorithms were selected for diagnostic analysis of the test set. Receiver operating characteristic (ROC) curve was used to evaluate the performance of the model. Draw decision curve analysis (DCA) to evaluate the clinical personalized medical value of the predictive model. The high/low subtypes of immune infiltration levels obtained by optimisation based on the Boruta algorithm were statistically different in the survival analysis of ccRCC patients. Multifactorial immune infiltration level combined with clinical factors better predicted survival of ccRCC patients, and ccRCC with high immune infiltration may benefit more from anti-PD-1 therapy. Among the eight machine learning models, ExtraTrees had the highest test and training set ROC AUCs of 1.000 and 0.753; in the test set, LR and LightGBM had the highest sensitivity of 0.615; LR, SVM, ExtraTrees, LightGBM and MLP had higher specificities of 0.789, 1.000, 0.842, 0.789 and 0.789, respectively; and LR, ExtraTrees and LightGBM had the highest accuracy of 0. 719, 0.688 and 0.719 respectively. Therefore, the CT-based ML achieved good predictive results in predicting immune infiltration in ccRCC, with the ExtraTrees machine learning algorithm being optimal. The use of radiomics model based on renal CT images can be noninvasively used to predict the immune infiltration level of ccRCC as well as combined with clinical information to create columnar plots predicting total survival in people with ccRCC and to predict responsiveness to ICI therapy, findings that may be useful in stratifying the prognosis of patients with ccRCC and guiding clinical practitioners to develop individualized regimens in the treatment of their patients.

Lung cancer remains the leading cause of cancer-related mortality worldwide, emphasizing the critical need for early pulmonary nodule detection to improve patient outcomes. Current methods encounter challenges in detecting small nodules and exhibit high false positive rates, placing an additional diagnostic burden on radiologists. This study aimed to develop a two-stage deep learning model integrating U-Net, Yolov8s, and the Swin transformer to enhance pulmonary nodule detection in computer tomography (CT) images, particularly for small nodules, with the goal of improving detection accuracy and reducing false positives. We utilized the LUNA16 dataset (888 CT scans) and an additional 308 CT scans from Tianjin Chest Hospital. Images were preprocessed for consistency. The proposed model first employs U-Net for precise lung segmentation, followed by Yolov8s augmented with the Swin transformer for nodule detection. The Shape-aware IoU (SIoU) loss function was implemented to improve bounding box predictions. For the LUNA16 dataset, the model achieved a precision of 0.898, a recall of 0.851, and a mean average precision at 50% IoU (mAP50) of 0.879, outperforming state-of-the-art models. The Tianjin Chest Hospital dataset has a precision of 0.855, a recall of 0.872, and an mAP50 of 0.862. This study presents a two-stage deep learning model that leverages U-Net, Yolov8s, and the Swin transformer for enhanced pulmonary nodule detection in CT images. The model demonstrates high accuracy and a reduced false positive rate, suggesting its potential as a useful tool for early lung cancer diagnosis and treatment.